Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Spire Health LSE:SPI London Ordinary Share GB00BNLPYF73 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  +1.30p +1.15% 114.80p 866,693 12:53:00
Bid Price Offer Price High Price Low Price Open Price
114.50p 114.90p 116.90p 109.10p 115.10p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 931.70 22.70 4.20 27.3 460.4

Spire Health (SPI) Latest News

More Spire Health News
Spire Health Takeover Rumours

Spire Health (SPI) Share Charts

1 Year Spire Health Chart

1 Year Spire Health Chart

1 Month Spire Health Chart

1 Month Spire Health Chart

Intraday Spire Health Chart

Intraday Spire Health Chart

Spire Health (SPI) Discussions and Chat

Spire Health Forums and Chat

Date Time Title Posts
18/1/201911:21Spire Health1,042
15/1/201713:48Spice Holdings PLC1,547
07/10/201101:44Stanard and Very Poor-
31/1/201018:33Man, a spiritual being or an animal?192
12/8/200010:36Spirent PLC-

Add a New Thread

Spire Health (SPI) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Spire Health trades in real-time

Spire Health (SPI) Top Chat Posts

Spire Health Daily Update: Spire Health is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker SPI. The last closing price for Spire Health was 113.50p.
Spire Health has a 4 week average price of 99.65p and a 12 week average price of 96.15p.
The 1 year high share price is 259.20p while the 1 year low share price is currently 96.15p.
There are currently 401,081,391 shares in issue and the average daily traded volume is 1,646,236 shares. The market capitalisation of Spire Health is £460,441,436.87.
eaaxs06: You seem to burst with glee and pleasure every time the share price drops, blueblood. I guess you must be trading a huge short position to be so elated every time and will do everything possible to highlight negative press or price weakness. Either that or you have a morbid sense of delight to see other investors suffer, not a trait I posses myself, but I guess it takes all sorts. Anyway, whatever your position, a very Merry Xmas and a Happy New Year to you and I hope you get everything you deserve to make you happy.
cantrememberthis2: Mediclinic last year had to write down £105m+ last year when share price was £2.25, from their initial 300p+ investment and stake of 29%. Do they write down another £120m from last year to todays share price circa 125p? Seems absurd when they COULD buy the remaining shares at substantially less than 300p, 225p in some ways. Why write off another £120m, on top of the £105m+ from previous years... i.e. £225m write down? Wow, you can by out some serious companies on the FTSE at the £250m region!!! Well,either way its been a VERY EXPENSIVE LESSON. Spire Healthcare on its knees at 125 from concerted shorting by the likes of Wallace LLP etc... who have shorted regularly from Mid Aug to as late as 8th Oct 18. The scenario created here through bad timing, NHS cost reductions and market apathy = OPPORTUNITY for others. MDC report 17OCT18. Also their CEO sits on the SPI board. Call me thick - but this is takeover territory and IF MDC are too slow to react could cost them with a predator lurking! Game on GLA, DYOR.
essentialinvestor: What are the negative comments?. At the tine of the bid I said Spire would be better to accept, and the sector faced challenges with cost pressures re margins, which may be underestimated. Posted that view long before the recent warning. Which of those has been incorrect, given recent results and a share price collapse since. Recently mentioned Spire now looked a sitting duck for a bid, however there's no guarantee. If you view any of that as negative, you are a very sensitive soul.
justiceforthemany: THE TIMES Meet the companies ripe for a share grab Spire Healthcare “Mediclinic217;s management will probably sigh with relief that they didn’t go ahead with a full takeover of Spire last year because the company’s shares have continued to slide. They briefly touched £1.50 a share after this week’s trading update and profit warning as NHS referrals dropped more than expected. The lower share price could tempt Mediclinic, which already owns 29.5 per cent, to return with a new offer, with Spire shareholders more willing to accept a price below last year’s offer price.”
eastbourne1982: Ebitda has changed though and as a result the bank covenants are going to become an issue soon, this is one of the main reasons for the share price fall, anything could happen here, you could get a bid however the share price could also go sub £1. A possible bid is the only positive in the short term, there are many negatives.
justiceforthemany: Spire's share price is now trading at the tangible assets value alone - if you take out all intangibles and goodwill. Crazy. Why would Mediclinic have offered 315p if Spire was truly only worth 150p? Healthcare is one of the few true defensives and will only grow with the ageing population.
jonwig: In the meantime, we downgrade our 2018 EBITDA by 16% and EPS by 37%, noting that this implies gearing of 3.7x EBITDA at the end of 2018 (covenant 4.0x). With the shares down by 20% since our upgrade, our waning confidence in our prior investment thesis prompts us to consider a stop-loss action. Our new valuation, based on EV/EBITDA and DCF metrics that reflect higher risk, leads to a 120p/share price target. We therefore set our recommendation to Sell, and believe there is potential for intangible asset write-downs and a dividend cut. Speculation regarding the potential for Mediclinic to acquire Spire helps to the limit downside, but Mediclinic’s five-year low share price, and the negative reaction to its previous bid for Spire, adds risk to relying on that get-out-of-jail-free card.
cantrememberthis2: E1982 = Very attractive share price for many non Private Investors IMO MDC Offered 315p Share Price 155p on print NHS is the NHS and skint So the news was no suprise People get ill, die etc... Its not a widow/orphans stock but man this is cheap.
che7win: Yes bounty, MDC might be barred from takeover for 6months, not sure, or unless someone else comes in with an offer.But nothing to stop others taking this over, plenty of US companies could use a weak exchange rate in their favour, never mind a weak SPI share price to offer 350p a share.Who knows, the chart has broken out from the low point though, would be nice to get to 300p from here short term.
tonysss13: Mediclinic said to weigh £1.8 billion plus takeover bid for Spire Healthcare Friday, 16 September 2016, 11:03 am Mediclinic is preparing to bid for Spire Healthcare, the FTSE 250 company that was formed from the sale of BUPA hospitals. According to excellent sources, Mediclinic is working with bankers from Morgan Stanley on the potential purchase of the remainder of Spire Healthcare that it doesn't own (remember last year Mediclinic bought 29.9pc of Spire Healthcare for 360p a share). Now, to be clear I'm not the first financial journalist to raise the prospect of a Mediclinic bid for Spire Healthcare. In late August, several British stock market reporters picked up on a note from JP Morgan, which theorised that now might be the right time for FTSE 100-listed Mediclinic to buy the remainder of Spire given the currency fluctuations post the Brexit referendum. I have pasted the relevant paragraphs from the JP Morgan note below: "In our view, the weakness in the GBP and strength of MDC’s share price vs Spire’s is an opportunity for MDC to consolidate its ownership of Spire (currently 29.9%). We estimate it could pay a 35% premium for Spire and see year one EPS increase by 3-4%, rising to 10% in year three assuming a debt-based deal. Alternatively, if MDC chose to raise equity ~£300m-500m (4-7%) in order to leave less gearing and also fund Spire’s London hospital expansion, year one accretion would drop to 2-1%. We note the authority to raise equity afforded Remgro, MDC’s largest shareholder (~44.6%), at its Aug-16th AGM." But from what I understand from excellent sources is bankers from Morgan Stanley, Mediclinic's financial advisers, are actually working on the deal suggested by the JP Morgan analyst. One source reckons Mediclinic is just a few weeks away from submitting a formal approach for Spire. I don't have much more information than that but I have been told any offer is likely to be at about a 30pc premium to the current share price. Mediclinic declined to comment. However, people familiar with the company tried to play down the tale, unsurprisingly. - See more at: hxxp://
Spire Health share price data is direct from the London Stock Exchange
Your Recent History
Spire Heal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190123 13:09:18